Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Zhi-Wei Wu, Fei Jin, Qing-Liang Li, Jia-Mei Gao, Hai-Song Zhou, Kai Duan, Zhao Gao, Yan Liu, Zhi-Yong Hao, Wei Chen, Yue-Yue Liu, Ge-Lin Xu, Biao Yang, Ben Dong, Jiu-Wei Zhang, Yu-Liang Zhao & Xiao-Ming Yang. (2023) Immunogenicity and safety of a new hexavalent rotavirus vaccine in Chinese infants: A randomized, double-blind, placebo-controlled phase 2 clinical trial. Human Vaccines & Immunotherapeutics 19:2.
Read now
Read now
Zhi-Wei Wu, Qing-Liang Li, Hai-Song Zhou, Kai Duan, Zhao Gao, Xin-Jiang Zhang, Zhi-Jun Jiang, Zhi-Yong Hao, Fei Jin, Xuan Bai, Qi Li, Ge-Lin Xu, Yu-Liang Zhao & Xiao-Ming Yang. (2021) Safety and immunogenicity of a novel oral hexavalent rotavirus vaccine：a phase I clinical trial. Human Vaccines & Immunotherapeutics 17:7, pages 2311-2318.
Read now
Read now
Yuxiao Wang, Jingxin Li, Pei Liu & Fengcai Zhu. (2021) The performance of licensed rotavirus vaccines and the development of a new generation of rotavirus vaccines: a review. Human Vaccines & Immunotherapeutics 17:3, pages 880-896.
Read now
Read now
Paul Gillard, Tsuyoshi Tamura, Haruo Kuroki, Yoshiyuki Morikawa, Leentje Moerman, Jose Parra, Yurina Kitamura, Kazuko Mihara & Arisa Okamasa. (2019) Immunogenicity and safety of the diphtheria, pertussis, tetanus and inactivated poliovirus vaccine when co-administered with the human rotavirus vaccine (Rotarix) in healthy Japanese infants: a phase IV randomized study. Human Vaccines & Immunotherapeutics 15:4, pages 800-808.
Read now
Read now
Daniel E. Velasquez, Umesh Parashar & Baoming Jiang. (2018) Decreased performance of live attenuated, oral rotavirus vaccines in low-income settings: causes and contributing factors. Expert Review of Vaccines 17:2, pages 145-161.
Read now
Read now
Articles from other publishers (7)
Hanna Bergman, Nicholas Henschke, Daniel Hungerford, Femi Pitan, Duduzile Ndwandwe, Nigel Cunliffe & Karla Soares-Weiser. (2021) Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database of Systematic Reviews 2021:11.
Crossref
Crossref
Zi-Wei Sun, Yu Fu, Hai-Ling Lu, Rui-Xia Yang, Hemant Goyal, Ye Jiang & Hua-Guo Xu. (2021) Association of Rotavirus Vaccines With Reduction in Rotavirus Gastroenteritis in Children Younger Than 5 Years. JAMA Pediatrics 175:7, pages e210347.
Crossref
Crossref
Courtney Gidengil, Matthew Bidwell Goetz, Sydne Newberry, Margaret Maglione, Owen Hall, Jody Larkin, Aneesa Motala & Susanne Hempel. (2021) Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis. Vaccine 39:28, pages 3696-3716.
Crossref
Crossref
Nguyen Minh Hai, Nguyen Dang Dung, Dinh Cong Pho, Vu Tung Son, Vu Ngoc Hoan, Phan Tan Dan, Bui Dang The Anh, La Huong Giang & Pham Ngoc Hung. (2021) Immunogenicity, safety and reactogenicity of ROTAVAC® in healthy infants aged 6–8 weeks in Vietnam. Vaccine 39:7, pages 1140-1147.
Crossref
Crossref
Julia M. Baker, Jacqueline E. Tate, Juan Leon, Michael J. Haber & Benjamin A. Lopman. (2019) Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries. PLOS Medicine 16:12, pages e1003005.
Crossref
Crossref
Karla Soares-Weiser, Hanna Bergman, Nicholas Henschke, Femi Pitan & Nigel Cunliffe. (2019) Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Zhaojun Mo, Xiao Ma, Peng Luo, Yi Mo, Susan S. Kaplan, Qiong Shou, Minghuan Zheng, Darcy A. Hille, Beth A. Arnold & Xueyan Liao. (2019) Immunogenicity of pentavalent rotavirus vaccine in Chinese infants. Vaccine 37:13, pages 1836-1843.
Crossref
Crossref